COEP - Coeptis Therapeutics Holdings, Inc.
13.19
0.730 5.534%
Share volume: 73,589
Last Updated: 03-06-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.17%
PREVIOUS CLOSE
CHG
CHG%
$12.46
0.73
0.06%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | |
|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | |
| Report Date | 08-16-2024 | 08-16-2024 | 11-13-2024 | 03-27-2025 | 05-14-2025 | 11-13-2025 | |
| Cash flow financing | 1.563 M | 1.944 M | 1.475 M | 731.971 K | 6.102 M | 5.064 M | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash flow | -439.890 K | 0.000 | 0.000 | -604.567 K | 3.735 M | 0.000 | |
| Net income | -3.001 M | -3.035 M | -1.829 M | -3.012 M | -3.421 M | -2.899 M | |
| Depreciation | 250.211 K | 250.211 K | 250.211 K | 250.212 K | 295.303 K | 295.303 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -100.000 K | 0.000 | 0.000 | 100.000 K | 0.000 | 0.000 | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | -100.000 K | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Cash Change | -439.890 K | 525.831 K | -417.623 K | -604.567 K | 3.735 M | 2.912 M |